Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Recruiting · NCT06064864 · Registry updated 2024-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2024-05-14 | NCT06064864 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
| Kyung Hee University Hospital | 5 |
| Kyungpook National University Hospital | 19 |
| Samsung Medical Center | 207 |
| Seoul National University Hospital | 277 |
| Severance Hospital | 45 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |